A late clinical stage biopharmaceutical company focused on developing oncolytic viral immunotherapies for the treatment of cancer patients.
Request +1, this is a great opportunity
A late clinical stage biopharmaceutical company focused on developing oncolytic viral immunotherapies for the treatment of cancer patients.
Request +1, this is a great opportunity